Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate Dems Try To Move Forward On Health Reform By Drawing From Past For Inspiration: Bill Clinton

This article was originally published in The Pink Sheet Daily

Executive Summary

President Clinton urges Democrats not to get entangled in crafting a perfect bill, given inevitable unintended consequences and future revisions.

You may also be interested in...

Many Blue Dogs Go Against House Bill Despite Concessions On Public Option

Blue Dog Democrats' "no" votes make House health reform vote a close one: Could more conservative Senate Finance Committee bill be ultimate template for reform?

Health Care Reform: Public Option In, Trigger Option Out

Senate Majority Leader Reid's decision to include a public option in the combined Senate bill suggests insurers made a misstep by exiting negotiations with congressional leaders and the White House.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts